Antibodies to Chondroitin Sulfate A–Binding Infected Erythrocytes: Dynamics and Protection during Pregnancy in Women Receiving Intermittent Preventive Treatment
The DOI matches its Crossref record; 15 of the 15 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Plasmodium falciparum parasites that cause malaria in pregnancy express unique variant surface antigens (VSAs). Levels of immunoglobulin G (IgG) antibody to pregnancy-associated VSAs measured at delivery are gravidity dependent, and they have been associated with protection from disease. It is not known how these IgG responses develop in pregnant women receiving intermittent preventive treatment during pregnancy (IPTp) or whether IgG levels in early pregnancy predict pregnancy outcomes. METHODS: We performed longitudinal measurements of IgG antibody to VSAs by flow cytometric analysis of serum samples obtained from 549 Malawian women receiving IPTp. We examined fluctuations in IgG levels over time and associated the IgG levels noted at study enrollment with clinical outcomes. RESULTS: Levels of IgG antibody to pregnancy-associated VSAs were gravidity dependent. Overall, levels decreased while women were receiving IPTp, but the levels of the individuals were highly dynamic. Primigravidae developed low levels of pregnancy-specific IgG, which were often boosted during second pregnancies. The prevalence of parasites was low (8.4% at enrollment and 2.4% in late pregnancy). Antibody levels at enrollment did not predict birth weight, duration of gestation at delivery, or the maternal hemoglobin level in late pregnancy. CONCLUSION: Levels of IgG antibody to pregnancy-specific VSAs decrease during receipt of IPTp. Antibody levels in early pregnancy did not predict clinical outcome. IPTp and decreasing malaria prevalence pose challenges for the evaluation of novel interventions for malaria during pregnancy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Epidemiology and burden of malaria in pregnancy
Desai, M., ter Kuile, F. O., Nosten, F., McGready, R., Asamoa, K., Brabin, B., & Newman, R. D. (2007) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(07)70021-x · Cited by 1,432
Adherence of Plasmodium falciparum to Chondroitin Sulfate A in the Human Placenta
Fried, M., & Duffy, P. E. (1996) · Science · doi:10.1126/science.272.5267.1502 · Cited by 1,108 · cited 1×
“These PRBCs express specific variant surface antigens (VSAs) that can bind chondroitin sulfate A (CSA), enabling their placental sequestration [2–4].”
BackgroundMalaria in pregnancy: pathogenesis and immunity
Rogerson, S. J., Hviid, L., Duffy, P. E., Leke, R. F., & Taylor, D. W. (2007) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(07)70022-1 · Cited by 628 · cited 1×
“first pregnancy) often lack such antibodies [5], which explains, in part, the susceptibility of such women to malaria [6].”
BackgroundSelf-citationEffect of a fall in malaria transmission on morbidity and mortality in Kilifi, Kenya
O'Meara, W. P., Bejon, P., Mwangi, T. W., Okiro, E. A., Peshu, N., Snow, R. W., Newton, C. R., & Marsh, K. (2008) · The Lancet · doi:10.1016/s0140-6736(08)61655-4 · Cited by 446
Changes in malaria indices between 1999 and 2007 in The Gambia: a retrospective analysis
Ceesay, S. J., Casals-Pascual, C., Erskine, J., Anya, S. E., Duah, N. O., Fulford, A. J., Sesay, S. S., Abubakar, I., Dunyo, S., Sey, O., et al. (2008) · The Lancet · doi:10.1016/s0140-6736(08)61654-2 · Cited by 425
Effects of Plasmodium vivax malaria in pregnancy.
Nosten, F., McGready, R., Simpson, J., Thwai, K., Balkan, S., Cho, T., Hkirijaroen, L., Looareesuwan, S., & White, N. (1999) · The Lancet · doi:10.1016/s0140-6736(98)09247-2 · Cited by 381
Ricke, C. H., Staalsoe, T., Koram, K., Akanmori, B. D., Riley, E. M., Theander, T. G., & Hviid, L. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.165.6.3309 · Cited by 303
Staalsoe, T., Shulman, C. E., Bulmer, J. N., Kawuondo, K., Marsh, K., & Hviid, L. (2004) · The Lancet · doi:10.1016/s0140-6736(03)15386-x · Cited by 288 · cited 2×
“In cross-sectional studies, antibodies to pregnancy-associated VSAs have been associated with protection from maternal anemia, premature birth, or LBW infants among subsets of women at delivery [7, 8].”
BackgroundBeeson, J. G., Brown, G. V., Molyneux, M. E., Mhango, C., Dzinjalamala, F., & Rogerson, S. J. (1999) · The Journal of Infectious Diseases · doi:10.1086/314899 · Cited by 266
Self-citationDuffy, P. E., & Fried, M. (2003) · Infection and Immunity · doi:10.1128/iai.71.11.6620-6623.2003 · Cited by 260 · cited 3×
“In cross-sectional studies, antibodies to pregnancy-associated VSAs have been associated with protection from maternal anemia, premature birth, or LBW infants among subsets of women at delivery [7, 8].”
BackgroundReducing the burden of malaria in pregnancy by preventive strategies
Menéndez, C., D'Alessandro, U., & ter Kuile, F. O. (2007) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(07)70024-5 · Cited by 188 · cited 1×
“IPTp and IgG Antibody to Malaria in Pregnancy • JID 2010:201 (1 May) • 1317 regardless of infection status—reduces the clinical effect of malaria in pregnancy [9], but it might also interfere with the acquisition and maintenance of pregnancy-specific malaria immunity [10].”
BackgroundStaalsoe, T., Megnekou, R., Fievét, N., Ricke, C. H., Zornig, H. D., Leke, R., Taylor, D. W., Deloron, P., & Hviid, L. (2001) · The Journal of Infectious Diseases · doi:10.1086/322809 · Cited by 161 · cited 4×
“Levels of pregnancy-specific IgG antibody have previously been noted to decrease in the postpartum period [20], and our study agrees with this finding, which is consistent with the hypothesis that exposure to these antigens is largely limited to pregnancy.”
ResultInfluentialRogerson, S. J., Mkundika, P., & Kanjala, M. K. (2003) · Journal of Clinical Microbiology · doi:10.1128/jcm.41.4.1370-1374.2003 · Cited by 113
Self-citationDuffy, M. F., Byrne, T. J., Elliott, S. R., Wilson, D. W., Rogerson, S. J., Beeson, J. G., Noviyanti, R., & Brown, G. V. (2005) · Molecular Microbiology · doi:10.1111/j.1365-2958.2005.04577.x · Cited by 93 · cited 1×
“falciparum lines that were used were the genetically distinct HCS3 and CS2 lines, which adhere to CSA [11, 12] and express var2csa as the dominant transcript [13].”
MethodSelf-citationFeng, G., Aitken, E., Yosaatmadja, F., Kalilani, L., Meshnick, S. R., Jaworowski, A., Simpson, J. A., & Rogerson, S. J. (2009) · The Journal of Infectious Diseases · doi:10.1086/599841 · Cited by 69 · cited 1×
“PRBCs [29, 30], are more relevant measures of immunity.”
BackgroundSelf-citation
Cited by
Burden, pathology, and costs of malaria in pregnancy: new developments for an old problem
Rogerson, S. J., Desai, M., Mayor, A., Sicuri, E., Taylor, S. M., & van Eijk, A. M. (2018) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(18)30066-5 · Cited by 306
Self-citationMalaria in pregnancy: small babies, big problem
Umbers, A. J., Aitken, E. H., & Rogerson, S. J. (2011) · Trends in Parasitology · doi:10.1016/j.pt.2011.01.007 · Cited by 200
Self-citationFried, M., & Duffy, P. E. (2017) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a025551 · Cited by 202
Unger, H. W., Ome-Kaius, M., Wangnapi, R. A., Umbers, A. J., Hanieh, S., Suen, C. S. L. W., Robinson, L. J., Rosanas-Urgell, A., Wapling, J., Lufele, E., et al. (2015) · BMC Medicine · doi:10.1186/s12916-014-0258-3 · Cited by 102
“In areas of moderateto-high endemicity, primigravidae are most at risk [5].”
BackgroundSelf-citationDesigning a VAR2CSA-based vaccine to prevent placental malaria
Fried, M., & Duffy, P. E. (2015) · Vaccine · doi:10.1016/j.vaccine.2015.10.011 · Cited by 86
Metadata
- Authors
- Aitken, E. H., Mbewe, B., Luntamo, M., Maleta, K., Kulmala, T., Friso, M., Fowkes, F. J. I., Beeson, J. G., Ashorn, P., & Rogerson, S. J.
- Venue
- The Journal of Infectious Diseases
- Publisher
- Oxford University Press (OUP)
- Published
- 2010-05
- Volume
- 201
- Issue
- 9
- Pages
- 1316-1325
- ISSN
- 0022-1899 (ISSN-L)
- 1537-6613
- OpenAlex
- W2118239281
- Cited by
- 42
- References
- 15
- FWCI
- 2.68
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.